JNJ 10191584 MALEATE

CAS869497-75-6

JNJ 10191584 MALEATE (CAS 869497-75-6, C17H19ClN4O5) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of JNJ 10191584 MALEATE
C17H19ClN4O5 · 394.81 g/mol
CAS No.
869497-75-6
Formula
C17H19ClN4O5
Mol. weight
394.81 g/mol

Chemical Specifications

Identifiers

CAS number 869497-75-6
Product name JNJ 10191584 MALEATE
Synonyms JNJ 10191584 MALEATE; 1-[(5-CHLORO-1H-BENZIMIDAZOL-2-YL)CARBONYL]-4-METHYLPIPERAZINE MALEATE; VUF 6002; JNJ 10191584 maleate salt; VUF 6002 maleate; VUF6002 maleate
Molecular formula C17H19ClN4O5
Molecular weight 394.81 g/mol

Physical and chemical properties

Boiling Point 232.6 ( ℃ )

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of JNJ 10191584 MALEATE?

The CAS Registry Number of JNJ 10191584 MALEATE is 869497-75-6. JNJ 10191584 MALEATE is also known as JNJ 10191584 MALEATE; 1-[(5-CHLORO-1H-BENZIMIDAZOL-2-YL)CARBONYL]-4-METHYLPIPERAZINE MALEATE; VUF 6002.

What is the molecular formula and molecular weight of JNJ 10191584 MALEATE?

The molecular formula of JNJ 10191584 MALEATE is C17H19ClN4O5, and its molecular weight is 394.81 g/mol.

How can I request a quotation for JNJ 10191584 MALEATE?

Send an inquiry for JNJ 10191584 MALEATE (CAS 869497-75-6) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for JNJ 10191584 MALEATE

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.